Senior Director, US Medical Affairs, Lymphoma
Bristol Myers Squibb
Summary
The Senior Director will support US Golcadomide and BCL6-LDD and report to the Executive Director, Lymphoma Medical Product Lead. This headquarters-based role leads a multidisciplinary team of physicians, pharmacists, and scientists.
Job description
The Senior Director provides scientific and medical leadership for approved and investigational lymphoma products, with a primary focus on golcadomide and BCL6-LDD. The role also leads integrated US Medical planning in partnership with Global Medical, Commercial, Clinical Research and Development, Regulatory, Translational Development, and Market Access.
The Senior Director helps shape and execute the US lymphoma medical strategy in alignment with US and Global Medical priorities. The role oversees the lymphoma medical plan, leads the US team, and coordinates evidence generation, including BMS-sponsored Medical Affairs studies, investigator-sponsored research, and external collaborations. The Senior Director also partners with Global Medical and US cross-functional teams to prepare for new product and indication launches.
Key Responsibilities
- Medical Strategy and Execution: Lead the development and execution of the US Lymphoma Medical Affairs strategy and tactical plan. Partner with US and Global stakeholders to set priorities, allocate resources, and monitor performance.
- Launch Readiness: Lead US Medical launch planning for golcadomide, BCL6-LDD, and future products or indications. Align evidence generation, scientific communications, medical education, field readiness, external engagement, and operations with US and Global partners.
- Therapy Implementation: Lead or support site readiness, safe administration, toxicity management, long-term follow-up, and expanded access programs for new lymphoma therapies, as appropriate.
- Training: Oversee high-quality lymphoma training for Medical, Sales, and other functions. Topics may include the disease and standard of care, competitive landscape, BMS-sponsored trials, and key publications.
- External Scientific Engagement: Serve as a key US Medical contact for healthcare professionals, investigators, KOLs, advisory boards, advocacy organizations, and cooperative groups. Represent BMS at congresses and scientific meetings, and provide compliant scientific direction for external engagements and lymphoma assets.
- Evidence Generation and Publications: Lead evidence-generation and publication activities for inline and pipeline lymphoma assets. Activities may include BMS-sponsored Medical Affairs studies, investigator-sponsored research, registries, digital health studies, and external collaborations. Ensure appropriate review, budget and resource oversight, timely delivery, quality, publication, and Good Clinical Practice compliance.
- Cross-Functional and Global Collaboration: Partner across US and Global Medical, Commercial, Clinical Development, Regulatory, Market Access, Pharmacovigilance, Statistics, Translational Research, Manufacturing and Quality, Project Leadership, and Field Medical to align priorities and advance the US lymphoma medical strategy.
- Team Leadership and Development: Lead the multidisciplinary Lymphoma Medical Affairs team and disease sub-teams. Set clear expectations, coach direct reports, and build scientific, operational, presentation, leadership, and strategic capabilities.
- Budget, Resource, and Timeline Planning: Partner with Finance and the Disease Lead to plan timelines, resources, and budgets for US Lymphoma Medical Affairs. Develop risk-adjusted spending forecasts and regularly review plans and performance.
Requirements
- Advanced degree in a health-related field preferred (MD, PharmD, or PhD), with hematology/oncology experience.
- At least 7 years of relevant clinical or industry experience, including Medical Affairs or equivalent experience, hematology/oncology expertise, and people management.
- At least 3–5 years of clinical research and development or study management experience in the biopharmaceutical industry.
- Strong knowledge of hematologic malignancies, clinical trial design, statistics, scientific data interpretation, Good Clinical Practice, and applicable ethical and regulatory requirements.
- A hematology publication record is preferred.
- Demonstrated ability to lead sizable, multicultural teams and work effectively across functions in a fast-changing, highly matrixed organization.
- Experience leading pharmaceutical evidence-generation activities, including company-sponsored studies, investigator-sponsored research, registries, or cooperative group studies.
- Experience developing regional or global medical, publication, and brand plans.
- Knowledge of industry trends and experience leading operational programs, initiatives, and change in a dynamic environment.
- Excellent interpersonal, facilitation, negotiation, writing, and presentation skills, with the ability to communicate complex information clearly and influence internal and external audiences.
- Strong strategic thinking, prioritization, analytical, organizational, and process improvement skills, with close attention to detail.
- Financial forecasting, budgeting, and resource-planning skills are preferred.
- Demonstrated customer focus and credibility with internal and external stakeholders.
- Willingness to travel as needed (less than 30%).
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Flexible Time Off
- Paid Company Holidays
- Paid Vacation
- Paid Sick Leave
- Paid Volunteer Days
- Summer Hours Flexibility
- Leaves Of Absence
- Annual Global Shutdown
- Discretionary Cash Incentives
- Stock Opportunities
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.